Skip to main content

New story in Health from Time: FDA Issues Warning About Hydroxychloroquine for COVID-19



On April 24, the U.S. Food and Drug Administration (FDA) issued a MedWatch Safety Alert about the use of hydroxychloroquine or chloroquine for treating COVID-19.

After preliminary studies hinted that hydroxychloroquine may help some patients with severe COVID-19 symptoms to improve, the FDA issued an emergency use authorization (EUA) to allow doctors to use the drug on hospitalized patients whose symptoms are not improving. Several studies were also launched to study its effects as a COVID-19 treatment.

However, hydroxychloroquine can have negative effects on the heart, contributing to abnormal heart rhythms that can be life-threatening. For those with existing heart problems, the dangers could be even greater, especially if the drug is combined with the antibiotic azithromycin, as some researchers treating COVID-19 patients have done. The American Heart Association, the American College of Cardiology and the Heart Rhythm Society jointly published cautionary guidelines recommending that doctors stop using hydroxychloroquine on patients at any sign of heart trouble.

The drugs are approved for treating malaria, and in the case of hydroxychloroquine, also for treating autoimmune disorders like rheumatoid arthritis and lupus. (In the U.S., hydroxychloroquine is more common since the malaria parasite is largely resistant to chloroquine.) For people taking the drug for an autoimmune disorder, their doctors monitor for signs of adverse heart events and can adjust dosage as needed.

The FDA’s safety alert doesn’t say those patients should stop taking the drugs they need, but instead warns general consumers to “not buy these medicines from online pharmacies without a prescription from your health care professional.” The alert stresses that hydroxychloroquine and chloroquine “should be used for COVID-19 only where patients can be appropriately monitored in the hospital as required by the EUA or are enrolled in a clinical trial with appropriate screening and monitoring.”

The FDA says that neither drug has been proven safe and effective in treating COVID-19. In fact, a study published on April 23 involving 368 COVID-19 patients at U.S. Veterans Health Administration hospitals found that taking hydroxychloroquine alone, or in combination with azithromycin, did not reduce the need for a ventilator compared to those not taking the drugs. Further, people taking hydroxychloroquine alone had a higher risk of dying during the study than those not taking the drug. Researchers in China came to a similar conclusion in a study of 150 COVID-19 patients randomly assigned to receive hydroxychloroquine or the current standard of care: after a month, both groups had similar symptom profiles, and showed similar levels of the virus, suggesting that the drug wasn’t clearing the COVID-19 virus in a significant way.

The National Institutes of Health is conducting an ongoing study of hydroxychloroquine among hospitalized patients, as is Novartis, whose Sandoz division makes a generic version of the drug.

Popular posts from this blog

New story in Health from Time: Here’s How Quickly Coronavirus Is Spreading in Your State

The novel coronavirus pandemic is a global crisis, a national emergency and a local nightmare. But while a great deal of the focus in the U.S. has been on the federal government’s response, widely criticized as slow and halting , the picture on the ground remains very different in different parts of the country. A TIME analysis of the per capita spread of the epidemic in all 50 states and Washington, D.C. found considerable range in the rate of contagion, and, in some parts of the country, a significant disparity compared to the national figure. The U.S., unlike nations such as South Korea and now Italy , has yet to show signs of bringing the runaway spread of the virus under control. However, while no single state is yet showing strong signs of bending the curve , some are faring much worse than others. The following graphic plots the rise in the total confirmed cases of COVID-19 per 100,000 residents in each state, plotted by the day that each state reported its first case....

New video by gymvirtual on YouTube

Rutina para adelgazar | Ejercicios para perder peso en casa ♥ ♥ LÉEME / DESPLIÉGAME ♥ ♥ Hola a todos, hoy os traigo una rutina de cardio de 25 minutos para quemar grasa y adelgazar en casa. En la web https://ift.tt/39VJREp encontraréis los calendarios de entrenamiento tanto para principiantes como para avanzados. Si quieres conseguir tú transformación en solamente 12 semanas, entra ya en http://www.pgv12.com y elige el PLAN PGV12 que más se adapte a ti. Nuestro lema: YO PUEDO CON TODO Los hashtags: #GymVirtual #YPCT #YoPuedoConTodo #PGV12 ♡♡ ¡SUSCRÍBETE! ♡♡ http://www.youtube.com/user/gymvirtual ................................................................................................................................. ♡♡ PLAN DE ENTRENAMIENTO + NUTRICIÓN 12 SEMANAS♡♡ http://www.pgv12.com ................................................................................................................................. ♡♡¡ECHA UN VISTAZO A NUESTRA TIENDA ONLINE! ♡♡ https://ift.tt/2Un...

New story in Health from Time: After Cruise Ships and Nursing Homes, Will Universities Be the Next COVID-19 Tinderboxes?

The fall semester has yet to begin, but student athletes training for the season can already be found on college campuses across the U.S. And so can COVID-19. Since the start of July there have been at least two outbreaks among student athletes, coaches, and staff—with 37 infected at the University of North Carolina (UNC) Chapel Hill and 22 at Boise State . Clusters of infection have been traced to college town bars popular with students. A common misconception is that young people with COVID-19 don’t die and therefore college re-openings pose little risk. Sadly, this isn’t the case. COVID-19 deaths in the young are rare, but they happen. Universities across the U.S. are mourning the loss of students in the lead-up to the school year, including Joshua Bush , a 30-year old nursing student at the University of South Carolina, Trevor Syphus Lee , a 27-year old senior at Utah Valley University, and Juan Garcia , a 21-year old Penn State undergraduate. One might imagine th...